Concepedia

Publication | Closed Access

Two-year outcomes of intravitreal ziv-aflibercept

DOI

29

Citations

23

References

2018

Year

Ahmad M. Mansour, Mohammed Ashraf, Abdulrazzak Charbaji, Muhammad H. Younis, Ahmed Souka, Avantika Dogra, Hana A. Mansour, Jay Chhablani
British Journal of Ophthalmology

Abstract

IVZ appears safe and efficacious in the therapy of macular diseases through 2 years.

References

YearCitations

Page 1